← Leaderboards
Gregory A Nichols
Kaiser Foundation Research Institute
$2,693,092
Attributed
$2,693,092
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $815.6K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,656,246 · 3
AHRQ$36,846 · 1
By mechanism
R18$1,914,041 · 1
R21$779,051 · 3
Top collaborators
No co-investigators on record.
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Richard W Grant$15,968,167
- Rachel Gold$17,398,894
- Teresa A Hillier$11,447,361
- Erin S Leblanc$7,994,574
- Anjali Gopalan$2,090,586
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusRegistriesData SetCardiovascular DiseasesComputerized Medical RecordEventMemberFollow-UpResponseRisk ReductionRisk FactorsCommunitiesCardiovascular Disorder RiskMortality Vital StatisticsCaringAdultCardiovascular Risk FactorAffectCardiovascular Disorder PreventionAspirinCompliance BehaviorCollaborationsCommunity HealthClinic
Grant awards (8)
Cumulative Glycemic Burden and Cardiovascular Disease Risk in Type 2 Diabetes$228,705
R21 · FY2013 · DK · contact PI
Dissemination of CVD risk factor treatment among diabetic patients in FQHCs$618,124
R18 · FY2012 · HL · contact PI
Cumulative Glycemic Burden and Cardiovascular Disease Risk in Type 2 Diabetes$197,500
R21 · FY2012 · DK · contact PI
Dissemination of CVD risk factor treatment among diabetic patients in FQHCs$610,761
R18 · FY2011 · HL · contact PI
Dissemination of CVD risk factor treatment among diabetic patients in FQHCs$685,156
R18 · FY2010 · HL · contact PI
Model Portability for Complex Patients$36,846
R21 · FY2009 · HS · contact PI
Characteristics and Costs of Impaired Fasting Glucose$158,000
R21 · FY2005 · DK
Characteristics and Costs of Impaired Fasting Glucose$158,000
R21 · FY2004 · DK